📊 Note: Daily ratings and analytics are updated after market close and will be available by 7:00 PM IST.

Details

NameSymbolSector
JENBURKT PHARMACEUTICALS LTD.JENBURPHPharmaceuticals
Open
1150.4
High
1168.9
Low
1127.05
Close
1147.05
Volume
830
Exchange
bse
Time
21-May-2026

Outlook

Score:  

5.5

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Jenburkt Pharmaceuticals is  
Spinning Top
Estimated Stoploss of Jenburkt Pharmaceuticals is ₹  
1168.9
Jenburkt Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
Spinning Top
 candle pattern indicates the trend direction of Jenburkt Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Jenburkt Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Jenburkt Pharmaceuticals is  
Upℹ
 by  

6.42

%. 
Target
Buy @ 

922.22

Sell @ 

1177.08

Current @ 

1147.05

Volume

The trade volumes of Jenburkt Pharmaceuticals have become  
Deficientℹ
Though the volume trend for Jenburkt Pharmaceuticals appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Jenburkt Pharmaceuticals is  

Down

 by  

47.49

% 

Valuation

The current market price of Jenburkt Pharmaceuticals is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 196cr and total assets worth ₹ 196cr, the balance sheet of Jenburkt Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Jenburkt Pharmaceuticals has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 3cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

52.94% i.e. ₹ 27cr earned in operatingℹ
33.33% i.e. ₹ 17cr spent in investingℹ
13.73% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Jenburkt Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

53.33% i.e. ₹ 8cr earned in operatingℹ
0% in investingℹ
46.67% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Income
The income of Jenburkt Pharmaceuticals is  

₹ 47cr

 and  

Profit

 is :  

₹ 10cr

(*Sep 2025)

Jenburkt Pharmaceuticals Profit is up by:  

42.86

% and Income is Up by:  

27.03

% 

(*Sep 2025)

The income of Jenburkt Pharmaceuticals is  

₹ 37cr

 and  

Profit

 is :  

₹ 7cr

(*Jun 2025)

Jenburkt Pharmaceuticals Profit is down by:  

12.5

% and Income is Down by:  

11.9

% 

(*Jun 2025)

The income of Jenburkt Pharmaceuticals is  

₹ 42cr

 and  

Profit

 is :  

₹ 8cr

(*Mar 2025)

Jenburkt Pharmaceuticals Profit is up by:  

33.33

% and Income is Up by:  

10.53

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.